These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 30746763

  • 1. The frequency of oral famotidine administration influences its effect on gastric pH in cats over time.
    Golly E, Odunayo A, Daves M, Vose J, Price J, Hecht S, Steiner JM, Hillsman S, Tolbert MK.
    J Vet Intern Med; 2019 Mar; 33(2):544-550. PubMed ID: 30746763
    [Abstract] [Full Text] [Related]

  • 2. Repeated Famotidine Administration Results in a Diminished Effect on Intragastric pH in Dogs.
    Tolbert MK, Graham A, Odunayo A, Price J, Steiner JM, Newkirk K, Hecht S.
    J Vet Intern Med; 2017 Jan; 31(1):117-123. PubMed ID: 27906465
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the effect of a famotidine continuous rate infusion on intragastric pH in healthy dogs.
    Hedges K, Odunayo A, Price JM, Hecht S, Tolbert MK.
    J Vet Intern Med; 2019 Sep; 33(5):1988-1994. PubMed ID: 31294879
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs.
    Tolbert K, Bissett S, King A, Davidson G, Papich M, Peters E, Degernes L.
    J Vet Intern Med; 2011 Sep; 25(1):47-54. PubMed ID: 21143305
    [Abstract] [Full Text] [Related]

  • 5. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
    Šutalo S, Ruetten M, Hartnack S, Reusch CE, Kook PH.
    J Vet Intern Med; 2015 Sep; 29(3):840-6. PubMed ID: 25966746
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the effect of orally administered acid suppressants on intragastric pH in cats.
    Parkinson S, Tolbert K, Messenger K, Odunayo A, Brand M, Davidson G, Peters E, Reed A, Papich MG.
    J Vet Intern Med; 2015 Jan; 29(1):104-12. PubMed ID: 25537303
    [Abstract] [Full Text] [Related]

  • 8. Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs.
    Kuhl A, Odunayo A, Price J, Hecht S, Marshall K, Steiner J, Tolbert MK.
    J Vet Intern Med; 2020 Mar; 34(2):678-683. PubMed ID: 32020689
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose famotidine and effervescent cimetidine in healthy subjects: a placebo-controlled overnight pH study.
    Reilly TG, Grimley CE, Usselmann B, Cottrell J, Mann SG, Raskin S, Nwokolo CU.
    Aliment Pharmacol Ther; 1998 May; 12(5):469-74. PubMed ID: 9663728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH.
    Reilly TG, Mann SG, Panos MZ, Walt RP.
    Gut; 1995 Sep; 37(3):325-8. PubMed ID: 7590425
    [Abstract] [Full Text] [Related]

  • 14. The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration.
    Decktor D, Houle JM, Pierce CH.
    Am J Ther; 1998 Mar; 5(2):97-100. PubMed ID: 10099044
    [Abstract] [Full Text] [Related]

  • 15. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
    Tutuian R, Katz PO, Ahmed F, Korn S, Castell DO.
    Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
    [Abstract] [Full Text] [Related]

  • 16. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
    Hedenström H, Alm C, Kraft M, Grahnén A.
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1137-41. PubMed ID: 9663842
    [Abstract] [Full Text] [Related]

  • 17. Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups.
    Shirai N, Furuta T, Xiao F, Kajimura M, Hanai H, Ohashi K, Ishizaki T.
    Aliment Pharmacol Ther; 2002 Apr; 16(4):837-46. PubMed ID: 11929404
    [Abstract] [Full Text] [Related]

  • 18. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
    Hunyady B, Juricskay I, Nagy L, Garamszegi M, Vincze A, Mózsik G.
    Eur J Clin Pharmacol; 1996 Apr; 50(6):449-56. PubMed ID: 8858270
    [Abstract] [Full Text] [Related]

  • 19. Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
    Furuta T, Shirai N, Sugimoto M, Nakamura A, Okudaira K, Kajimura M, Hishida A.
    Aliment Pharmacol Ther; 2005 Jul 01; 22(1):67-74. PubMed ID: 15963082
    [Abstract] [Full Text] [Related]

  • 20. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
    Abe Y, Inamori M, Togawa J, Kikuchi T, Muramatsu K, Chiguchi G, Kawamura H, Kobayashi N, Kirikoshi H, Sakaguchi T, Takamura T, Nakajima A, Ueno N, Sekihara H.
    J Gastroenterol; 2004 Jan 01; 39(1):21-5. PubMed ID: 14767730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.